LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 60 filers reported holding LEAP THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $47,518 | – | 105,595 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 150,142 | $268,000 | 0.02% |
| Alyeska Investment Group, L.P. | 514,285 | $921,000 | 0.01% |
| A.R.T. Advisors, LLC | 15,461 | $28,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,300 | $65,000 | 0.00% |
| Lindbrook Capital, LLC | 1,500 | $2,000 | 0.00% |
| US BANCORP \DE\ | 6,100 | $11,000 | 0.00% |
| Asset Planning Services, Ltd. | 100 | $0 | 0.00% |
| FMR LLC | 1,563,124 | $2,798,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 164,493 | $294,000 | 0.00% |